全文获取类型
收费全文 | 90045篇 |
免费 | 6070篇 |
国内免费 | 2404篇 |
专业分类
耳鼻咽喉 | 390篇 |
儿科学 | 1990篇 |
妇产科学 | 919篇 |
基础医学 | 5948篇 |
口腔科学 | 326篇 |
临床医学 | 12299篇 |
内科学 | 25665篇 |
皮肤病学 | 152篇 |
神经病学 | 3646篇 |
特种医学 | 6474篇 |
外国民族医学 | 9篇 |
外科学 | 9955篇 |
综合类 | 16199篇 |
现状与发展 | 5篇 |
预防医学 | 3115篇 |
眼科学 | 492篇 |
药学 | 6697篇 |
66篇 | |
中国医学 | 2814篇 |
肿瘤学 | 1358篇 |
出版年
2024年 | 126篇 |
2023年 | 1341篇 |
2022年 | 1954篇 |
2021年 | 3691篇 |
2020年 | 3592篇 |
2019年 | 3140篇 |
2018年 | 3142篇 |
2017年 | 3045篇 |
2016年 | 3167篇 |
2015年 | 3268篇 |
2014年 | 6398篇 |
2013年 | 6492篇 |
2012年 | 5390篇 |
2011年 | 5746篇 |
2010年 | 4804篇 |
2009年 | 4556篇 |
2008年 | 4543篇 |
2007年 | 4559篇 |
2006年 | 4178篇 |
2005年 | 3504篇 |
2004年 | 2824篇 |
2003年 | 2455篇 |
2002年 | 2007篇 |
2001年 | 1873篇 |
2000年 | 1474篇 |
1999年 | 1306篇 |
1998年 | 1217篇 |
1997年 | 1159篇 |
1996年 | 850篇 |
1995年 | 901篇 |
1994年 | 786篇 |
1993年 | 659篇 |
1992年 | 623篇 |
1991年 | 497篇 |
1990年 | 444篇 |
1989年 | 370篇 |
1988年 | 346篇 |
1987年 | 309篇 |
1986年 | 259篇 |
1985年 | 314篇 |
1984年 | 259篇 |
1983年 | 136篇 |
1982年 | 181篇 |
1981年 | 141篇 |
1980年 | 122篇 |
1979年 | 102篇 |
1978年 | 80篇 |
1977年 | 56篇 |
1976年 | 52篇 |
1975年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 968 毫秒
51.
《Saudi Pharmaceutical Journal》2022,30(6):669-678
BackgroundIschemia reperfusion (I/R) play an imperative role in the expansion of cardiovascular disease. Sinomenine (SM) has been exhibited to possess antioxidant, anticancer, anti-inflammatory, antiviral and anticarcinogenic properties. The aim of the study was scrutinized the cardioprotective effect of SM against I/R injury in rat.MethodsRat were randomly divided into normal control (NC), I/R control and I/R + SM (5, 10 and 20 mg/kg), respectively. Ventricular arrhythmias, body weight and heart weight were estimated. Antioxidant, inflammatory cytokines, inflammatory mediators and plasmin system indicator were accessed.ResultsPre-treated SM group rats exhibited the reduction in the duration and incidence of ventricular fibrillation, ventricular ectopic beat (VEB) and ventricular tachycardia along with suppression of arrhythmia score during the ischemia (30 and 120 min). SM treated rats significantly (P < 0.001) altered the level of antioxidant parameters. SM treatment significantly (P < 0.001) repressed the level of creatine kinase MB (CK-MB), creatine kinase (CK) and troponin I (Tnl). SM treated rats significantly (P < 0.001) repressed the tissue factor (TF), thromboxane B2 (TXB2), plasminogen activator inhibitor 1 (PAI-1) and plasma fibrinogen (Fbg) and inflammatory cytokines and inflammatory mediators.ConclusionOur result clearly indicated that SM plays anti-arrhythmia effect in I/R injury in the rats via alteration of oxidative stress and inflammatory reaction. 相似文献
52.
53.
Atsushi Hata Takahiro Nakajima Keisuke Matsusaka Masaki Fukuyo Junichi Morimoto Takayoshi Yamamoto Yuichi Sakairi Bahityar Rahmutulla Satoshi Ota Hironobu Wada Hidemi Suzuki Hisahiro Matsubara Ichiro Yoshino Atsushi Kaneda 《International journal of cancer. Journal international du cancer》2020,146(2):388-399
54.
55.
56.
《Journal of vascular and interventional radiology : JVIR》2020,31(5):760-768.e1
PurposeTo investigate dynamic variables obtained from retrospective computed tomography angiography for ability to predict thoracic endovascular aortic repair (TEVAR) outcomes in patients with complicated type B aortic dissection (cTBAD).Materials and MethodsSeventy-nine patients with cTBAD who received TEVAR from March 2009 to June 2018 were retrospectively enrolled. Relative true lumen area (r-TLA) was computed at the level of tracheal bifurcation every 5% of all R-R intervals. Parameters that reflect the state of intimal motion were evaluated, including difference between maximum and minimum r-TLA (D-TLA) and true lumen collapse. The endpoints comprised early (≤ 30 days) and late (> 30 days) outcomes after intervention.ResultsOverall early mortality rate was 13.9% (11/79), and early adverse events rate was 24.1% (19/79). Patients who received TEVAR within 2 days of symptom onset demonstrated the worst outcomes. A longer time of r-TLA < 25% in 1 cardiac cycle (P = .049) and larger D-TLA (P < .001) were correlated to an increased early death. In addition, D-TLA was an independent predictor of early mortality. Area under the curve of D-TLA was 0.849 (95% confidence interval 0.730–0.967) for predicting early mortality and 0.742 (95% CI 0.611–0.873) for predicting early adverse events. Survival and event-free survival rates during follow-up were decreased in the D-TLA > 21.5% group compared with the D-TLA ≤ 21.5% group (all P < .001).ConclusionsLarger D-TLA is correlated with worse postoperative outcomes and might be a crucial parameter for future risk stratification in patients with cTBAD. 相似文献
57.
58.
59.
患者男,22岁,无明显诱因咳嗽、痰中带血1周,起初干咳,后咳痰并痰中带血,偶咯出少量暗红色血液;无发热、盗汗、乏力,无胸闷、胸痛及呼吸困难,平素体健,无家族病史。查体:双肺呼吸音稍粗,右肺下叶闻及细湿啰音。胸部增强CT:右肺下叶基底段见片状磨玻璃影,内见直径约8mm粗大供血动脉自腹腔干发出;支气管树分支及肺发育正常,未见隔离肺(图1A^1C)。肺动脉CTA示右下肺基底段动脉部分缺如(图1D),考虑为右下肺异常体动脉供血并周围肺组织肺泡出血可能。 相似文献
60.
目的探讨自血穴位注射疗法联合马来酸茚达特罗治疗老年稳定期慢性阻塞性肺疾病(COPD)的临床疗效及其对患者炎性因子、免疫功能及肺功能的影响。 方法将2015年5月至2016年5月我院收治的86例老年缓解期COPD患者分为观察组与对照组。对照组给予马来酸茚达特罗治疗,观察组在对照组治疗基础上另给予自血穴位注射疗法。治疗12周后,评价2组临床疗效。治疗前及治疗12周后,分别检测2组患者肺功能指标(FEV1、FVC与PEF),炎性因子(IL-8、α1-AT、IL-6及TNF-α),免疫功能指标(IgG、IgA、CD3+及CD4+)水平。治疗期间,对2组患者的不良反应进行密切观察。 结果治疗后二组患者各项检测指标均优于治疗前。治疗12周后,观察组总有效率为90.7%,明显高于对照组的72.1%(P<0.05)。治疗12周后,观察组FEV1、FVC与PEF等肺功能指标,IgG、IgA、CD3+及CD4+等免疫功能指标水平均明显高于对照组(P<0.05),而IL-8、α1-AT、IL-6及TNF-α含量分别为(23.23±3.87)ng/L、(3.43±0.41)g/L、(52.25±5.38)ng/L及(43.12±3.98)ng/L,改善程度均明显优于对照组(P<0.05)。治疗期间,2组患者均未出现严重不良反应。 结论自血穴位注射疗法联合马来酸茚达特罗治疗老年稳定期COPD疗效确切,可有效改善患者炎症水平,值得进行深入研究。 相似文献